Table 1.

Social, demographic, and medical characterisation of study participants by vaccine

		Ad26.COV2-S (n=64 997)	BNT162b2 (n=400 136)	ChAdOx1 nCoV-19 (n=265 730)	CoronaVac (n=683 284)	Fully vaccinated with any vaccine (n=1 414 147)	Unvaccinated (n=1 414 147)
Age
Median, years		65·0 (62·0–70·0)	66·0 (63·0–69·0)	66·0 (63·0–70·0)	72·0 (64·0–80·0)	68·0 (63·0–75·0)	68·0 (63·0–75·0)
Age group
	60–69 years	48 553 (74·7%)	301 302 (75·3%)	188 934 (71·1%)	282 196 (41·3%)	820 205 (58·0%)	820 205 (58·0%)
	70–79 years	13 064 (20·1%)	87 630 (21·9%)	69 621 (26·2%)	219 334 (32·1%)	390 304 (27·6%)	390 304 (27·6%)
	≥80 years	3380 (5·2%)	11 204 (2·8%)	7175 (2·7%)	181 754 (26·6%)	203 638 (14·4%)	203 638 (14·4%)
Sex
Male		34 118 (52·8%)	175 260 (43·8%)	128 879 (48·5%)	308 161 (45·1%)	646 265 (45·7%)	64 626 (45·7%)
Female		30 679 (47·2%)	224 876 (56·2%)	136 851 (51·5%)	375 123 (54·9%)	767 882 (54·3%)	767 882 (54·3%)
Affiliation regime to the health system
Contributory		12 674 (19·5%)	194 066 (48·5%)	104 698 (39·4%)	263 748 (38·6%)	575 558 (40·7%)	575 558 (40·7%)
Subsidised		52 323 (80·5%)	206 070 (51·5%)	161 032 (60·6%)	419 536 (61·4%)	838 589 (59·3%)	838 589 (59·3%)
Comorbidities
At least one comorbidity		10 725 (16·5%)	102 435 (25·6%)	67 230 (25·3%)	204 302 (29·9%)	384 648 (27·2%)	384 648 (27·2%)
Cancer		325 (0·5%)	4401 (1·1%)	2657 (1·0%)	6833 (1·0%)	14 141 (1·0%)	14 141 (1·0%)
Diabetes		2665 (4·1%)	28 810 (7·2%)	18 601 (7·0%)	51 246 (7·5%)	101 818 (7·2%)	101 818 (7·2%)
Chronic kidney disease		1235 (1·9%)	14 405 (3·6%)	9034 (3·4%)	38 264 (5·6%)	62 222 (4·4%)	62 222 (4·4%)
Hypertension		9880 (15·2%)	93 232 (23·3%)	61 915 (23·3%)	192 686 (28·2%)	357 779 (25·3%)	357 779 (25·3%)
HIV		65 (0·1%)	400 (0·1%)	266 (0·1%)	0	1414 (0·1%)	1414 (0·1%)

Data are median (IQR) or n (%). On account of the matching process, data for vaccinated and unvaccinated cohorts are identical.